MAUREEN GALDAMEZ: Open Payments
NPI 1164662334 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 46 payments from 14 companies in 2025. Trend: 2023 $687 · 2024 $589 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $229 |
| ABBVIE INC. | 9 | $153 |
| Novo Nordisk Inc | 10 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $135 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Amgen Inc. | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: ZAVZPRET, QULIPTA, NURTEC ODT, Wegovy, AIRSUPRA, FARXIGA, VRAYLAR, Ozempic.
Industry payments across FL — which companies pay providers there.
